Tobacco Documents Online

f P.O.. BOX 2370 RESTON, VIRGlNIA TELEPHONE 703-620-4646 SCHNEIDERMAN LEAVES FIELD STUDIES; S(BAL NAMED ACTING DCCP DEPUTY CHf1=F Two major personnel changes in the Div. of Cancer Cause & Prevention were announced at the first meeting of the division's Board of Scientific Coun- selors. - Marvin Schneiderman, longtime chief of Field ~ I Studies & Statistics, revealed that he is leaving that, ~ position Nov. I to become associate NCI director for f science policy, in the office of Director Arthur Upton. Upton told the President's Cancer Panel that "I've been concerned about the degree to which the Office of Director•is isolated from the scientific activity of ; NCL" He said he created the Office of Science Policy , to fill that gap, and that Schneiderman also would ; work with him in liaison activity with other HEW offices and agencies outside the department as well j as with organizations in the private sector. He also will help with legislative duties- and preparing reports toCongress. Schneiderman thus follows the path trod earlier by two of his former DCCP coIIeagues-James Peters, ousted DCCP director, and John Moloney, who was removed by Upton as head of the Viral Oncology Program as a prelude to dismantling that program. ( Peters and Moloney were assigned to Upton's office, I with PetLrs eventually Ie?.ving the government. "I don't feel I'm being kicked upstairs," 'Schneider- man told The Cancer Letter. "1'f I felt that way, I would leave. I look forward to the new job as an in- teresting and challenging one, and one where I hope I can make a contribution." O'Conor also announced that Louis Sibal had been named as his acting deputy director. Gio Gori, still the deputy director of record, is spending part of his time pursuing master of public health studies tLt Johns Hopkins Univ., part of his time at NCI working with the Smoking & Health Program, and much of his time on the Baltimore-Washington Parkway. Gori's status when he returns full time next June is yet to be determined: O'Conor did not tell the Board, as reported in the Blue Sheet, that Gori would nqt rgturn to hrCl. In all probability, Gori will not be back as deputy director, but he says he intends to stay at NCI. Upton has said Gori is welcome to stay, the dispute over Gori's article on less hazardous cigarettes notwithstanding, but has not determined what job he will have. Sibal was deputy director of the Viral Oncology Program, and temporarily headed it after Moloney left. _ TIMN 0164983